Acridine

Acridine

SCHEMBL6427751

N.N.c1ccc2nc3ccccc3cc2c1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.94
MAPT P10636 3/20 0.94
HPGD P15428 3/20 0.94
GLA P06280 2/20 0.94
ACHE P22303 1/20 0.94
HTR3A P46098 1/20 0.62
NQO2 P16083 2/20 0.60
KDM4E B2RXH2 3/20 0.54
GAA P10253 3/20 0.54
KMT2A Q03164 3/20 0.54
NPC1 O15118 2/20 0.54
POLB P06746 2/20 0.54
LMNA P02545 1/20 0.54
PTBP1 P26599 1/20 0.54
RAB9A P51151 1/20 0.54
RCE1 Q9Y256 1/20 0.54
TDP1 Q9NUW8 1/20 0.50
STAT3 P40763 1/20 0.50
MEN1 O00255 1/20 0.48
USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acridine SCHEMBL31147979 1.00 ALDH1A1 (0.94) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL462843 1.00 ALDH1A1 (0.94) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL28062881 0.97 MAPT (0.88) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL4972293 0.97 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL3045498 0.97 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL1772714 0.97 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL8339 0.97 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL29352289 0.97 ALDH1A1 (1.00) ALDH1A1MAPTHPGDGLAACHE
Anthracene SCHEMBL9879830 0.94 MAPT (0.94) ALDH1A1MAPTHPGDGLAACHE
Acridine SCHEMBL1551975 0.94 ALDH1A1 (0.94) ALDH1A1MAPTHPGDGLAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11579152-B2 Engineered hERG channel proteins, vesicles and methods of identifying small molecule pharmacological agents THE ROCKEFELLER UNIVERSITY (US) 2023-02-14 US claimed
US-20210102956-A1 ASSAY FOR hERG CHANNEL SENSITIVITY TO SMALL MOLECULE PHARMACOLOGICAL AGENTS UNIV ROCKEFELLER (US) 2021-04-08 US claimed
EP-3435955-A1 ASSAY FOR hERG CHANNEL SENSITIVITY TO SMALL MOLECULE PHARMACOLOGICAL AGENTS The Rockefeller University (US) 2019-02-06 EP claimed
CN-104487446-B The method for reducing aggregation content in protein formulation using the multi-functional surface of mixing 新加坡科技研究局 2018-05-29 CN claimed
US-20170280984-A1 POLYMER-TYPE FLUORESCENT MOLECULE PROBE MAEDA HIROSHI (JP) 2017-10-05 US claimed
WO-2017173257-A1 ASSAY FOR hERG CHANNEL SENSITIVITY TO SMALL MOLECULE PHARMACOLOGICAL AGENTS THE ROCKEFELLER UNIVERSITY (US) 2017-10-05 WO claimed
CN-104487446-A Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations AGENCY SCIENCE TECH & RES 2015-04-01 CN claimed
US-20140294735-A1 POLYMER-TYPE FLUORESCENT MOLECULE PROBE HIROSHI MAEDA (JP) 2014-10-02 US claimed
EP-2774625-A1 POLYMER-TYPE FLUORESCENT MOLECULE PROBE Maeda, Hiroshi (JP) 2014-09-10 EP claimed
US-11579152-B2 Engineered hERG channel proteins, vesicles and methods of identifying small molecule pharmacological agents THE ROCKEFELLER UNIVERSITY (US) 2023-02-14 US disclosed
US-20210102956-A1 ASSAY FOR hERG CHANNEL SENSITIVITY TO SMALL MOLECULE PHARMACOLOGICAL AGENTS UNIV ROCKEFELLER (US) 2021-04-08 US disclosed
US-10946109-B2 Polymer-type fluorescent molecule probe HIROSHI MAEDA (JP) 2021-03-16 US disclosed
CN-105189530-B The chromatogram purification antibody from shortage chromatinic cell culture harvest object 新加坡科技研究局 2019-06-07 CN disclosed
CN-106752954-B CCB high sealing water-repellent paint 广东鼎新高新科技股份有限公司 2019-04-02 CN disclosed
CN-104487446-A Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations AGENCY SCIENCE TECH & RES 2015-04-01 CN disclosed
US-20140294735-A1 POLYMER-TYPE FLUORESCENT MOLECULE PROBE HIROSHI MAEDA (JP) 2014-10-02 US disclosed
EP-2774625-A1 POLYMER-TYPE FLUORESCENT MOLECULE PROBE Maeda, Hiroshi (JP) 2014-09-10 EP disclosed
WO-2005118580-A2 TRICYCLIC COMPOUNDS AS INHIBITORS OF THE HYPOXIC SIGNALING PATHWAY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH (US) 2005-12-15 WO disclosed
EP-0649656-B1 Pharmaceutical compositions based on acriflavine useful for the treatment of herpes and zona RICHARD LAB M (FR) 2001-08-16 EP disclosed
EP-0649656-A1 Pharmaceutical compositions based on acriflavine useful for the treatment of herpes and zona LABORATOIRE M. RICHARD (FR) 1995-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140294735-A1 POLYMER-TYPE FLUORESCENT MOLECULE PROBE PBRM1, EPCAM, CD44 ALDH1A1 1962/4885MAPT 1589/4885HPGD 2468/4885
US-10946109-B2 Polymer-type fluorescent molecule probe MKI67, PBRM1, CD44 ALDH1A1 1844/4885MAPT 1355/4885HPGD 2482/4885
US-20170280984-A1 POLYMER-TYPE FLUORESCENT MOLECULE PROBE MKI67, PBRM1, CD44 ALDH1A1 1844/4885MAPT 1355/4885HPGD 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.